|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| C07K 14/47 | |||
| A61K 48/00 | |||
| C07K 16/40 | |||
| C12N 15/00 | |||
| A61P 25/28 | |||
| A61P 3/10 | |||
| A61P 41/00 | |||
| A61P 13/12 | |||
| A61K 38/55 | |||
| A61P 1/00 | |||
| A61P 1/02 | |||
| A61P 1/04 | |||
| A61P 1/16 | |||
| A61P 1/18 | |||
| A61P 3/00 | |||
| A61P 3/08 | |||
| A61P 5/00 |
| (11) | Patento numeris | 3013353 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14734003.8 |
| Europos patento paraiškos padavimo data | 2014-06-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/001736 |
| Data | 2014-06-26 |
| (87) | Numeris | WO 2014/206563 |
| Data | 2014-12-31 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2013/0018 | 2013-06-26 | WO | |
| PCT/EP2013/0018 | 2013-06-27 | WO |
| (72) |
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
|
| (73) |
Xigen Inflammation Ltd.,
Arch. Makariou III 195 Neocleous House, 3030 Limassol,
CY
|
| (54) | CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS |
| CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS |